Table 1.
Potential fluid biomarkers of mild TBI
Marker | Process or structure affected |
Research findings in mild TBI | |
---|---|---|---|
Cerebrospinal fluid | Blood | ||
Cerebrospinal fuid:serum albumin ratio | Blood–brain barrier | Detection method not sensitive enough to changes in concentration53,54 | NA |
Interleukins and other acute-phase infammatory response proteins | Neuroinfammation | NA | NA |
Total tau protein | Axon | Levels peak 4–10 days after injury54,71 | Elevated levels in hypoxic brain injury;101,102 studies in mild TBI are lacking |
Myelin basic protein | Axon | NA | Detection methods not sensitive in mild TBI79 |
Neuroflament light polypeptide | Axon | Levels peak 4–10 days after injury54,71 | NA |
Neuroflament heavy polypeptide | Axon | NA | NA |
γ-Enolase | Neuron | Levels confounded by lysis of red blood cells in blood-contaminated cerebrospinal fuid82 | Serum levels very sensitive to lysis of red blood cells in blood-contaminated cerebrospinal fuid82 |
S100-B | Astroglial cells | Levels are elevated, but a less sensitive marker than tau protein and neuroflaments71 | Results may be confounded by release from extracerebral tissues77 |
Glial fbrillary acidic protein | Astroglial cells | Elevated levels, but a less sensitive marker than tau and neuroflament proteins54,71 | Serum levels correlate with changes on brain imaging;118 extracerebral protein has not been detected74 |
Secreted APP-α and APP-β | Axon | NA | NA |
Amyloid-β40 and amyloid-β42 | Plaque pathology | No change in levels57,74 | NA |
Spectrin breakdown products | Neuron | NA | NA |
Ubiquitin carboxyl-terminal hydrolase isoenzyme L1 | Neuron | NA | One pilot study showed promising results123 |
Peripheral blood mononuclear small noncoding RNA molecules | Unknown | NA | One pilot study suggests altered expression of three RNA molecules in mild-TBI-exposed military personnel125 |
Abbreviations: APP, amyloid precursor protein; NA, not available; TBI, traumatic brain injury.